163 related articles for article (PubMed ID: 23554968)
1. Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.
Huxley RR; Lopez FL; MacLehose RF; Eckfeldt JH; Couper D; Leiendecker-Foster C; Hoogeveen RC; Chen LY; Soliman EZ; Agarwal SK; Alonso A
PLoS One; 2013; 8(3):e59052. PubMed ID: 23554968
[TBL] [Abstract][Full Text] [Related]
2. Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.
Kalogeropoulos AS; Tsiodras S; Rigopoulos AG; Sakadakis EA; Triantafyllis A; Kremastinos DT; Rizos I
BMC Cardiovasc Disord; 2011 Dec; 11():77. PubMed ID: 22204652
[TBL] [Abstract][Full Text] [Related]
3. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
[TBL] [Abstract][Full Text] [Related]
4. MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study.
Buckley LF; Agha AM; Dorbala P; Claggett BL; Yu B; Hussain A; Nambi V; Chen LY; Matsushita K; Hoogeveen RC; Ballantyne CM; Shah AM
Circ Heart Fail; 2023 Nov; 16(11):e010849. PubMed ID: 37753653
[TBL] [Abstract][Full Text] [Related]
5. Adhesion pathway proteins and risk of atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis.
Mendez IJ; Manemann SM; Bell EJ; Larson NB; Decker PA; Guerrero MA; Hanson NQ; Heckbert SR; Pankow JS; Tsai MY; Bielinski SJ
BMC Cardiovasc Disord; 2021 Sep; 21(1):436. PubMed ID: 34521347
[TBL] [Abstract][Full Text] [Related]
6. MMP-9 in atrial remodeling in patients with atrial fibrillation.
Lewkowicz J; Knapp M; Tankiewicz-Kwedlo A; Sawicki R; Kamińska M; Waszkiewicz E; Musiał WJ
Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):285-91. PubMed ID: 25869465
[TBL] [Abstract][Full Text] [Related]
7. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
[TBL] [Abstract][Full Text] [Related]
8. Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study).
Norby FL; Tang W; Pankow JS; Lutsey PL; Alonso A; Steffen BT; Chen LY; Zhang M; Shippee ND; Ballantyne CM; Boerwinkle E; Coresh J; Folsom AR
Am J Cardiol; 2021 Dec; 161():42-50. PubMed ID: 34794617
[TBL] [Abstract][Full Text] [Related]
9. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
[TBL] [Abstract][Full Text] [Related]
12. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
[TBL] [Abstract][Full Text] [Related]
13. Plasma total testosterone and risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.
Berger D; Folsom AR; Schreiner PJ; Chen LY; Michos ED; O'Neal WT; Soliman EZ; Alonso A
Maturitas; 2019 Jul; 125():5-10. PubMed ID: 31133217
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study.
Nambi V; Morrison AC; Hoogeveen RC; Coresh J; Miles S; Rhodes CE; Sharrett AR; Boerwinkle BE; Ballantyne CM
Tex Heart Inst J; 2008; 35(4):388-94. PubMed ID: 19156230
[TBL] [Abstract][Full Text] [Related]
15. Atrial extracellular matrix remodelling in patients with atrial fibrillation.
Polyakova V; Miyagawa S; Szalay Z; Risteli J; Kostin S
J Cell Mol Med; 2008; 12(1):189-208. PubMed ID: 18194448
[TBL] [Abstract][Full Text] [Related]
16. Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.
Willeit K; Pechlaner R; Willeit P; Skroblin P; Paulweber B; Schernthaner C; Toell T; Egger G; Weger S; Oberhollenzer M; Kedenko L; Iglseder B; Bonora E; Schett G; Mayr M; Willeit J; Kiechl S
JAMA Cardiol; 2017 May; 2(5):516-523. PubMed ID: 28355442
[TBL] [Abstract][Full Text] [Related]
17. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
Marín F; Pascual DA; Roldán V; Arribas JM; Ahumada M; Tornel PL; Oliver C; Gómez-Plana J; Lip GY; Valdés M
Am J Cardiol; 2006 Jan; 97(1):55-60. PubMed ID: 16377284
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
Nakano Y; Niida S; Dote K; Takenaka S; Hirao H; Miura F; Ishida M; Shingu T; Sueda T; Yoshizumi M; Chayama K
J Am Coll Cardiol; 2004 Mar; 43(5):818-25. PubMed ID: 14998623
[TBL] [Abstract][Full Text] [Related]
19. Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study.
Alonso A; Misialek JR; Eckfeldt JH; Selvin E; Coresh J; Chen LY; Soliman EZ; Agarwal SK; Lutsey PL
J Am Heart Assoc; 2014 Sep; 3(5):e001082. PubMed ID: 25237047
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis.
Kubota Y; Alonso A; Heckbert SR; Norby FL; Folsom AR
Heart Lung Circ; 2019 Apr; 28(4):615-622. PubMed ID: 29685716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
